Hydroxyurea affects T-lymphocyte subsets in sickle cell disease.

被引:0
|
作者
Sivasubramaniam, D [1 ]
Bekoe, O [1 ]
Motwani, B [1 ]
Allen, S [1 ]
Feldman, L [1 ]
Beaman, K [1 ]
Gilman-Sachs, A [1 ]
Feldman, LE [1 ]
机构
[1] Mt Sinai Hosp Med Ctr, Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Chicago, IL USA
关键词
D O I
10.1182/blood.V104.11.3726.3726
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3726
引用
收藏
页码:17B / 18B
页数:2
相关论文
共 50 条
  • [41] HYDROXYUREA AND SICKLE-CELL DISEASE
    ORRINGER, EP
    PARKER, JC
    HEMATOLOGIC PATHOLOGY, 1992, 6 (04) : 171 - 178
  • [42] Hydroxyurea for children with sickle cell disease
    Heeney, Matthew M.
    Ware, Russell E.
    PEDIATRIC CLINICS OF NORTH AMERICA, 2008, 55 (02) : 483 - +
  • [43] The role of hydroxyurea in sickle cell disease
    Halsey, C
    Roberts, IAG
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (02) : 177 - 186
  • [44] Hydroxyurea (hydroxycarbamide) for sickle cell disease
    Rankine-Mullings, Angela E.
    Nevitt, Sarah J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (09):
  • [45] Effects of hydroxyurea in sickle cell disease
    Lima, CSP
    Arruda, VR
    Costa, FF
    Saad, STO
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 122 - 122
  • [46] Hydroxyurea for Children with Sickle Cell Disease
    Heeney, Matthew M.
    Ware, Russell E.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 24 (01) : 199 - +
  • [47] Hydroxyurea (hydroxycarbamide) for sickle cell disease
    Nevitt, Sarah J.
    Jones, Ashley P.
    Howard, Jo
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (04):
  • [48] A multicentre clinical trial to confirm the usefulness of hydroxyurea with or without erythropoietin for sickle cell disease.
    ElHazmi, MAF
    Harakati, M
    Warsy, AS
    Mohareb, F
    Huraib, S
    AlMomen, AK
    CLINICAL CHEMISTRY, 1996, 42 (06) : 643 - 643
  • [49] Prospective study of splenic hypofunction during therapy with hydroxyurea in patients with sickle cell disease.
    Muraca, MF
    Sharma, S
    Gilday, D
    Brown, E
    Nili, N
    Olivieri, F
    BLOOD, 1999, 94 (10) : 415A - 415A
  • [50] Hydroxyurea is safe and effective in 2 to 5 year old children with sickle cell disease.
    Hoppe, C
    Quirolo, K
    Vichinsky, E
    Van Warmerdam, J
    Allen, K
    Styles, L
    BLOOD, 1999, 94 (10) : 417A - 417A